Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell and spatial transcriptomic analyses of gene therapy-associated retinal inflammation in non-human primates.

Molecular therapy. Advances·2026
Same author

Functional methods for evaluating the efficacy of retinal optogenetic therapy for vision restoration.

Frontiers in neuroscience·2026
Same author

Evaluation of Routine Clinical Deployment of an Autonomous Artificial Intelligence Assistant for Cataract Follow-Up in the National Health Service.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Adaptation of visual responses in degenerating <i>rd10</i> and healthy mouse retinas during ongoing electrical stimulation.

Frontiers in neuroscience·2026
Same author

Longitudinal Changes of Fundus Autofluorescence and Correlation With Visual Acuity in ABCA4-Associated Stargardt Disease.

Investigative ophthalmology & visual science·2026
Same author

Geographic atrophy in age-related macular degeneration: phenotypic characterisation for clinical trial consideration.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same journal

En face localization of retinal telangiectatic capillaries using OCT compared with ICG angiography in chronic vascular macular oedema.

Acta ophthalmologica·2026
Same journal

Usher syndrome-related visual impairment in Finland: A 35-year nationwide register-based study (1985-2019).

Acta ophthalmologica·2026
Same journal

Three years of ocular proton therapy in the Netherlands, clinical results.

Acta ophthalmologica·2026
Same journal

Risk factors for acquisition and severity of Acanthamoeba and Fusarium keratitis in contact lens users-A case-control and clinical-epidemiological study, 2009-2020.

Acta ophthalmologica·2026
Same journal

Distinguish polypoidal choroidal vasculopathy through choroidal alterations: A systematic review, meta-analysis and narrative synthesis.

Acta ophthalmologica·2026
Same journal

Ocular blood flow and retinal oxygen saturation measurements in central retinal artery occlusion.

Acta ophthalmologica·2026
See all related articles

Related Experiment Video

Updated: Dec 23, 2025

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
09:29

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

Published on: February 11, 2014

13.4K

Highest reported visual acuity after electronic retinal implantation.

Jasmina Cehajic Kapetanovic1,2, Nicole Troelenberg3, Thomas L Edwards1,2

  • 1Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, UK.

Acta Ophthalmologica
|April 29, 2020
PubMed
Summary
This summary is machine-generated.

This report describes a patient with severe vision loss who achieved record-breaking visual acuity after receiving a subretinal implant and completing a specialized, intensive visual training program. The findings highlight how structured rehabilitation can significantly improve functional sight in individuals using electronic devices to restore vision.

Keywords:
electronic prosthesisinherited retinal degenerationretinal implantvisual rehabilitationUSH2Aprostheticsblindnessoptogenetics

Frequently Asked Questions

More Related Videos

Implantation and Recording of Wireless Electroretinogram and Visual Evoked Potential in Conscious Rats
11:22

Implantation and Recording of Wireless Electroretinogram and Visual Evoked Potential in Conscious Rats

Published on: June 29, 2016

9.1K
Techniques for Processing Eyes Implanted with a Retinal Prosthesis for Localized Histopathological Analysis: Part 2 Epiretinal Implants with Retinal Tacks
10:00

Techniques for Processing Eyes Implanted with a Retinal Prosthesis for Localized Histopathological Analysis: Part 2 Epiretinal Implants with Retinal Tacks

Published on: February 14, 2015

12.5K

Related Experiment Videos

Last Updated: Dec 23, 2025

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
09:29

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

Published on: February 11, 2014

13.4K
Implantation and Recording of Wireless Electroretinogram and Visual Evoked Potential in Conscious Rats
11:22

Implantation and Recording of Wireless Electroretinogram and Visual Evoked Potential in Conscious Rats

Published on: June 29, 2016

9.1K
Techniques for Processing Eyes Implanted with a Retinal Prosthesis for Localized Histopathological Analysis: Part 2 Epiretinal Implants with Retinal Tacks
10:00

Techniques for Processing Eyes Implanted with a Retinal Prosthesis for Localized Histopathological Analysis: Part 2 Epiretinal Implants with Retinal Tacks

Published on: February 14, 2015

12.5K

Area of Science:

  • Ophthalmology and visual science research within electronic retinal implantation
  • Advanced retinal degeneration clinical outcomes research

Background:

No prior work had resolved the full potential of visual rehabilitation following the surgical placement of electronic retinal devices. That uncertainty drove clinicians to investigate whether intensive training could enhance patient outcomes. Prior research has shown that retinal implants provide a pathway for restoring sight in cases of advanced degeneration. However, the extent of functional improvement remained largely anecdotal across various clinical trials. This gap motivated the current report on a patient who underwent a structured training regimen. Investigators sought to determine if such an intervention could push the boundaries of existing visual performance metrics. Previous studies often focused primarily on the hardware capabilities rather than the plasticity of the visual system post-surgery. Understanding these limits is necessary for optimizing future therapeutic strategies for patients with profound vision loss.

Purpose Of The Study:

The study aimed to report the highest attained visual acuity using an electronic retinal implant following an intensive period of visual training. Researchers sought to address the gap in understanding how rehabilitation influences functional outcomes in patients with advanced retinal degeneration. The motivation stemmed from the need to maximize the utility of existing sight-restoration technologies. No prior work had fully characterized the potential for visual improvement through structured training after device implantation. The authors investigated whether this novel approach could enhance the visual percepts of a patient with no useful light perception. By documenting this case, the team intended to provide a benchmark for future clinical expectations. The project specifically examined the Retina Implant Alpha AMS device within the context of a multi-centre trial. This effort was driven by the desire to improve the quality of life for individuals suffering from severe, progressive vision loss.

Main Methods:

The review approach focused on a single case study derived from a prospective, international, multi-centre, interventional clinical trial. Researchers evaluated a patient diagnosed with USH2A-related degeneration who received a subretinal device in their worse-seeing eye. The team implemented a novel, intensive period of visual training to maximize the patient's sensory processing capabilities. Clinical staff monitored the device's functionality and safety profile over a three-year post-surgical duration. They assessed visual performance using standardized decimal, LogMAR, and Snellen scales to ensure objective comparisons. The investigators also documented the patient's ability to navigate obstacles and perceive distances in diverse lighting environments. This methodology prioritized the longitudinal observation of functional gains following the structured rehabilitation intervention. The study design allowed for the detailed characterization of visual improvements in a real-world setting.

Main Results:

The patient achieved the highest visual acuity ever recorded with an electronic retinal device, reaching 0.04 decimal. This result is equivalent to 1.39 LogMAR or 20/500 Snellen, allowing for real, digitally unenhanced reading. The device remained fully functional with no safety concerns throughout the three-year follow-up period. Beyond reading, the patient demonstrated the ability to identify obstacles and evaluate distances effectively. These functional gains were observed consistently in both daylight and night-time settings. The report confirms that the patient had no useful perception of light prior to the surgical intervention. These findings represent a significant milestone in the performance of subretinal implants for advanced degeneration. The data suggest that intensive training is a key factor in unlocking the potential of these electronic systems.

Conclusions:

The authors propose that intensive training protocols are necessary to maximize the functional benefits of electronic retinal implants. This synthesis suggests that visual rehabilitation should be a standard component of post-surgical care. The findings indicate that patients can achieve reading-level vision through consistent and structured practice sessions. These results imply that the visual cortex retains significant capacity for adaptation even after long periods of blindness. The researchers suggest that similar training models might benefit patients receiving other emerging therapies like optogenetic stimulation. This study provides a benchmark for future performance expectations in the field of retinal prosthetics. The authors conclude that the combination of hardware and rehabilitation offers a viable path for restoring meaningful visual function. These implications emphasize the importance of patient-centered approaches in the ongoing development of sight-restoration technologies.

The patient achieved a visual acuity of 0.04 decimal, which corresponds to 1.39 LogMAR or 20/500 Snellen. This performance enabled the individual to perform real, unenhanced reading tasks, marking the highest level of visual function documented for this specific electronic device.

The patient utilized the Retina Implant Alpha AMS, a subretinal device designed for individuals with advanced retinal degeneration. This technology functions by stimulating the remaining inner retinal cells to generate visual percepts in patients who previously lacked useful light perception.

The subretinal placement is necessary because it allows the device to interact directly with the inner retinal layers. This positioning facilitates the stimulation of remaining neural circuits, which is required to bypass the damaged photoreceptors in patients with USH2A-related degeneration.

The study utilized data from a prospective, international, multi-centre, interventional clinical trial. This design allowed researchers to track the device's safety and functionality over a three-year period, ensuring that the reported visual gains were stable and not associated with adverse surgical events.

Researchers measured the patient's ability to identify obstacles and evaluate distances in both daylight and night-time environments. These metrics demonstrated that the visual improvements extended beyond static reading tasks to include functional navigation and spatial awareness in varied lighting conditions.

The researchers propose that these findings have implications for optogenetics, as both approaches aim to stimulate inner retinal cells. By demonstrating the efficacy of intensive training, the authors suggest that future therapies targeting these cells may also benefit from structured visual rehabilitation protocols.